Author

Keita Watanabe

Kyoto University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Akari NishidaiD· 1 shared Hironori KatohiD· 1 shared Ikuo KimuraiD· 1 shared Mayu YamanoiD· 1 shared Miki IgarashiiD· 1 shared Nobuo SasakiiD· 1 shared Takako IkedaiD· 1 shared Yuki Masujima· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

Akari NishidaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

The pivotal role of a novel free fatty acid receptor GPR164 in the intestinal barrier function

Takako Ikeda, Yuki Masujima, Keita Watanabe, Akari Nishida, Mayu Yamano, Miki Igarashi, Nobuo Sasaki, Hironori Katoh, Ikuo Kimura

This study shows that GPR164 deletion in mice causes intestinal barrier dysfunction, Wnt/β-catenin signaling disruption, and IBD-like symptoms, suggesting GPR164 as a therapeutic target for IBD.

bioRxiv · Feb 20, 2025 · PreprintPhysiology